DAPASUG-ST-100

Description:

• DAPASUG-ST-100 is a fixed-dose combination tablet containing sitagliptin phosphate monohydrate 100 mg and dapagliflozin propanediol monohydrate 10 mg. This formulation is designed to enhance glycemic control in adults with type 2 diabetes mellitus by leveraging the complementary mechanisms of a DPP-4 inhibitor and an SGLT2 inhibitor.
• As a reputed dapagliflozin tablet manufacturer and one of the leading dapagliflozin tablet wholesalers, we provide consistent, high-quality supply for healthcare providers. Our extensive network also includes trusted dapagliflozin tablet distributors and acts as a reliable wholesale trader of diabetic medicine to meet bulk and retail demands. Plus, for those looking to buy dapagliflozin tablet online, we ensure authenticity and compliance with all regulatory standards.

Key Features:

• Combines the glucose-lowering effects of sitagliptin and dapagliflozin to provide comprehensive glycemic control.
• Sitagliptin enhances insulin secretion and suppresses glucagon release in a glucose-dependent manner.
• Dapagliflozin promotes urinary glucose excretion by inhibiting renal glucose reabsorption.
• The dual-action approach aids in significant HbA1c reduction and supports weight management.
• Once-daily oral dosing improves patient adherence and convenience.

Usage Guidelines:

• Administer orally once daily, with or without food, as directed by a healthcare professional.
• Suitable for adults with type 2 diabetes mellitus requiring combination therapy for improved glycemic control.
• Regular monitoring of renal function is recommended to ensure safe use of dapagliflozin.

Safety Profile:

• Common side effects may include nasopharyngitis, headache, and urinary tract infections.
• Not recommended for patients with type 1 diabetes or diabetic ketoacidosis.
• Caution is advised in patients with renal impairment or a history of pancreatitis.

Uses / Indications: A highly potent, reversible and selective sodium-glucose contransporter-2 inhibitor indicated worldwide for the treatment of Type 2 diabetes